Free Trial
→ Here's the last trade you should make before heading out for the weekend tomorrow. (From Timothy Sykes) (Ad) Free AMLX Stock Alerts

Amylyx Pharmaceuticals (AMLX) SEC Filings & 10K Form

Amylyx Pharmaceuticals logo
$6.57 +0.16 (+2.50%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$6.68 +0.11 (+1.75%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Amylyx Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
06/25/2025
4:24 PM		Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
05/12/2025
8:05 AM		Adage Capital Management, L.P. (Filed by)
Amylyx Pharmaceuticals (Subject)
Form SCHEDULE 13G
05/08/2025
6:01 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:04 AM		Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
6:05 AM		Amylyx Pharmaceuticals (Filer)
Form DEF 14A
04/24/2025
6:09 AM		Amylyx Pharmaceuticals (Filer)
Form DEFA14A
04/24/2025
6:13 AM		Amylyx Pharmaceuticals (Filer)
Form ARS
04/02/2025
4:22 PM		Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
4:12 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
4:14 PM		Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:52 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
11:15 PM		Amylyx Pharmaceuticals (Filer)
Form EFFECT
03/24/2025
3:15 PM		Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:32 PM		Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:34 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:28 PM		Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:28 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
7:30 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:32 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:32 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:30 AM		Amylyx Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/04/2025
5:24 AM		Amylyx Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2025
5:07 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
5:14 AM		Amylyx Pharmaceuticals (Filer)
Form POSASR
02/26/2025
3:35 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM		Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
Form SCHEDULE 13G/A
02/06/2025
7:17 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:54 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:55 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
3:58 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
3:55 PM		Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:53 PM		Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/10/2025
4:13 PM		Amylyx Pharmaceuticals (Filer)
Form 424B5
01/10/2025
4:23 PM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
5:05 AM		Amylyx Pharmaceuticals (Filer)
Form 424B5
01/08/2025
4:29 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
4:26 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:50 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
4:21 PM		Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
7:22 AM		Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:07 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
11/06/2024
6:24 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
9:56 AM		Amylyx Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/25/2024
4:38 PM		Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
10/17/2024
8:12 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
5:48 PM		Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:50 PM		Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:53 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
5:53 PM		Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
4:56 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
4:39 PM		Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
4:30 PM		Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:55 PM		Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
Form 4/A
09/05/2024
6:26 PM		Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
5:49 PM		Amylyx Pharmaceuticals (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
08/08/2024
6:09 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:14 AM		Amylyx Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
6:09 AM		Amylyx Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
3:32 PM		Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AMLX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
A grave, grave error.
Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...
Porter & Company | Sponsored
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...
Crypto 101 Media | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored